Skip to content

Effectiveness and Acceptance of Chatbot-Based Virtual Assistants on Medication Adherence, Neutrophil-Lymphocyte Ratio, and Psychological Problems Among Patients with Diabetes Mellitus

Effectiveness and Acceptance of Chatbot-Based Virtual Assistants on Medication Adherence, Neutrophil-Lymphocyte Ratio, and Psychological Problems Among Patients with Diabetes Mellitus

Status
Unknown
Phases
Phase 2Phase 3
Study type
Interventional
Source
TCTR
Registry ID
TCTR20240810004
Enrollment
78
Registered
2024-08-10
Start date
2024-07-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes mellitus (T2DM) is a group of chronic metabolic disorders distinguished by abnormal insulin sensitivity and increased blood glucose concentration. Low levels of medication adherence, psychological problems, and high levels of neutrophil-lymphocyte ratio are important factors for detecting developing complications. Chatbot, diabetes mellitus, medication adherence, psychological, virtual-assistant

Interventions

The intervention with chatbot consisted of 16 messages motivational, medical adharence information, and kind of intervenention psychological problems by delevering with WhatsApp. After the respondents
Experimental Behavioral,Active Comparator Behavioral
Chatbot-Based Virtual Assistants,Standart Care

Sponsors

None listed

Eligibility

Sex/Gender
All
Age
21 Years to 60 Years

Inclusion criteria

Inclusion criteria: (1) Age over 21 years with a diagnosis of T2DM who has psychological problems; (2) Have unadequate or poor medication compliance; (3) Can read and understand Bahasa Indonesian; (4) Have the ability to write messages on WhatsApp; and (5) Have a smartphone with Android, and have internet access.

Exclusion criteria

Exclusion criteria: (1) Had a disability, auditory deficiencies, or dementiat that would interfere with the use of chatbot-based VA;(2) Are pregnant and are unwilling to be a respondent; (3) Previously received hatbot-based VA intervention

Design outcomes

Primary

MeasureTime frame
Medication adherence (low, moderate, high adherence ) 2 times Modified Morisky Scale-8 (MMAS-8),Psychological Problems such as stress, depression and anxiety 2 times Depresion, Anxiety, and Stres Scale-21 (DASS-21)

Secondary

MeasureTime frame
Neutrophil-Lymphocyte Ratio 2 times Laboratorium,Loneliness 2 times UCLA Loneliness Scale

Countries

Indonesia

Contacts

Public ContactYohanes Andy Rias

Institut Ilmu Kesehatan Bhakti Wiyata Kediri

yohanes.andi@iik.ac.id085707388190

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026